TVTX
#1192
Travere Therapeutics, Inc. - Common Stock
67.5 2 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.60%
Monthly Change
+20.46%
6 month change
+130.60%
Year Change
+134.69%
Previous Close
67.1 2
Open
67.5 2
Low
67.5 2
High
67.5 2
Volume
95
Financials
- Market Capitalization 6.36 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-131.76
Price to sales ratio
6.95
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1179 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 99.75 USD | +1.26% | +2.15% | -10.97% | +42.24% | 6.48 B USD | ||
| 1185 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.09 USD | +1.01% | +3.75% | -8.80% | +136.69% | 6.44 B USD | ||
| 1201 |  LQDA Liquidia Corporation - Common Stock | 69.94 USD | -1.99% | -1.37% | -19.44% | +209.47% | 6.26 B USD | ||
| 1202 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 111.54 USD | +0.70% | +1.00% | +9.22% | +350.85% | 6.24 B USD |
Frequently asked questions about Travere Therapeutics, Inc. Common Stock
What is the Travere Therapeutics, Inc. Common Stock stock price today?
The current price of Travere Therapeutics, Inc. Common Stock (TVTX) is 67.52. Over the past 24 hours, the stock has changed by +0.60%. Follow the TVTX chart for real-time price dynamics.
What is the stock ticker of Travere Therapeutics, Inc. Common Stock?
Travere Therapeutics, Inc. Common Stock trades under the ticker TVTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Travere Therapeutics, Inc. Common Stock stock going up?
TVTX has changed by +4.23% over the last week, +20.46% over the last month, and +134.69% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Travere Therapeutics, Inc. Common Stock?
Travere Therapeutics, Inc. Common Stock currently has a market capitalization of 6.36 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Travere Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Travere Therapeutics, Inc. Common Stock reported earnings of -0.37 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Travere Therapeutics, Inc. Common Stock revenue for the last quarter?
Travere Therapeutics, Inc. Common Stock reported quarterly revenue of 169.58 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Travere Therapeutics, Inc. Common Stock net income for the last quarter?
Travere Therapeutics, Inc. Common Stock reported net income of -34.8 M for the last quarter. The previous quarter showed -37.1 M, which means net income changed by +6.21%.
How many employees does Travere Therapeutics, Inc. Common Stock have?
As of the latest available data, Travere Therapeutics, Inc. Common Stock has 497 employees. Workforce size can provide additional context about the company's scale and operations.
What is Travere Therapeutics, Inc. Common Stock EBITDA?
Travere Therapeutics, Inc. Common Stock EBITDA is 8.19 M, and its EBITDA margin is 4.83%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Travere Therapeutics, Inc. Common Stock stock?
You can buy Travere Therapeutics, Inc. Common Stock (TVTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Travere Therapeutics, Inc. Common Stock stock?
Investing in Travere Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TVTX chart and related analysis on metatrader.com as part of your research.